Announcement of Participation of NCI on PA-07-279: Bioengineering Research Grants (BRG)(R01), and on PA-06-418: Exploratory/Developmental Bioengineering Research Grants (EBRG)(R21)


Notice Number: NOT-CA-09-036

Key Dates
Release Date: September 29, 2009

Issued by
National Cancer Institute (NCI), (www.cancer.gov)

Purpose

As an addendum to NOT-EB-09-003, the National Cancer Institute (NCI) informs all interested applicants that it has re-joined and will continue to participate in funding opportunity announcement (FOA) PA-07-279, entitled Bioengineering Research Grants (BRG)(R01), and in FOA PA-06-418, entitled Exploratory/Developmental Bioengineering Research Grants (EBRG)(R21), until the FOAs expire on January 8, 2010.

The NCI-applicable Catalog of Federal Domestic Assistance (CFDA) numbers are: 93.393; 93.394; 93.395; 93.396; and 93.399.

The following institutes are participating in PA-07-279

National Cancer Institute (NCI), (www.cancer.gov)
National Eye Institute (NEI), (http://www.nei.nih.gov/)
National Human Genome Research Institute (NHGRI), (http://www.genome.gov)
National Institute on Alcohol Abuse and Alcoholism (NIAAA), (http://www.niaaa.nih.gov)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), (http://www.niams.nih.gov)
National Institute of Biomedical Imaging and Bioengineering (NIBIB), (http://www.nibib.nih.gov)
National Institute on Deafness and Communication Disorders (NIDCD), (http://www.nidcd.nih.gov)
National Institute of Dental and Craniofacial Research (NIDCR), (http://www.nidcr.nih.gov)
National Institute on Drug Abuse (NIDA), (http://www.nida.nih.gov)
National Institute of Environmental Health Sciences (NIEHS), (http://www.niehs.nih.gov)
National Institute of Neurological Disorders and Stroke (NINDS), (http://www.ninds.nih.gov)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), (http://www.nichd.nih.gov)

All other aspects of PA-07-279 and PA-06-418 remain unchanged.

Inquiries

Houston Baker, Ph.D.
Imaging Technology Development Branch
Cancer Imaging Program
Division of Cancer Treatment and Diagnosis
National Cancer Institute (NCI)
6130 Executive Boulevard, EPN Room 6060, MSC 7312
Bethesda, MD 20892-7412 (for U.S. Postal Service express or regular mail)
Rockville, MD 20852 (for non-USPS delivery)
Telephone: 301-594-9117 or 301-496-9531
Fax: 301-480-3507
E-mail: [email protected]